140 related articles for article (PubMed ID: 16336218)
1. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
Ragnarsson L; Yasuda T; Lewis RJ; Dodd PR; Adams DJ
J Neurochem; 2006 Jan; 96(1):283-91. PubMed ID: 16336218
[TBL] [Abstract][Full Text] [Related]
2. Effect of Conantokin G on NMDA receptor-mediated spontaneous EPSCs in cultured cortical neurons.
Alex AB; Baucum AJ; Wilcox KS
J Neurophysiol; 2006 Sep; 96(3):1084-92. PubMed ID: 16760339
[TBL] [Abstract][Full Text] [Related]
3. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
4. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
5. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
Barton ME; White HS; Wilcox KS
Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
7. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ
Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
[TBL] [Abstract][Full Text] [Related]
8. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
9. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.
Wittekindt B; Malany S; Schemm R; Otvos L; Maccecchini ML; Laube B; Betz H
Neuropharmacology; 2001 Nov; 41(6):753-61. PubMed ID: 11640930
[TBL] [Abstract][Full Text] [Related]
10. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
Klein RC; Prorok M; Galdzicki Z; Castellino FJ
J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
[TBL] [Abstract][Full Text] [Related]
11. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors.
Donevan SD; McCabe RT
Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
[TBL] [Abstract][Full Text] [Related]
14. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
Sheng Z; Prorok M; Castellino FJ
Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
[TBL] [Abstract][Full Text] [Related]
15. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
16. Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.
Twede VD; Teichert RW; Walker CS; Gruszczyński P; Kaźmierkiewicz R; Bulaj G; Olivera BM
Biochemistry; 2009 May; 48(19):4063-73. PubMed ID: 19309162
[TBL] [Abstract][Full Text] [Related]
17. The effects of alanine-substituted conantokin-G and ifenprodil on the human spermine-activated N-methyl-D-aspartate receptor.
Tsai VW; Dodd PR; Lewis RJ
Neuroscience; 2005; 130(2):457-64. PubMed ID: 15664702
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.
Klein RC; Galdzicki Z; Castellino FJ
Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277
[TBL] [Abstract][Full Text] [Related]
20. Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons.
Xing GG; Wang R; Yang B; Zhang D
Eur J Neurosci; 2006 Dec; 24(11):2987-92. PubMed ID: 17156360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
